Answers are grounded in this paper and cite their sources.
Many therapeutic drugs currently in use are cationic amphiphiles. These cationic amphiphilic drugs (CADs) induce phospholipidosis in humans and experimental animals. The recent study shows that CAD-induced cellular phospholipidosis is linked to the impairment of phospholipid catabolism by inhibition of lysosomal phospholipase A2 activity.
No takes yet. Share an insight, caveat, or question.
Abe et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: